We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$51.7B
| $204M | 0.28% |
2,729,279
+298,351
| +12% | +$23M |
|
102
Zimmer Biomet
ZBH
$18.4B
| $201M | 0.28% |
1,575,527
+289,193
| +22% | +$33.6M |
|
103
Synchrony
SYF
$25.6B
| $198M | 0.28% |
6,025,770
-3,595,621
| -37% | -$123M |
|
104
Truist Financial
TFC
$64B
| $198M | 0.28% |
4,599,362
-1,227,569
| -21% | -$53.8M |
|
105
Broadcom
AVGO
$2.04T
| $193M | 0.27% |
3,454,130
+68,130
| +2% | +$3.42M |
|
|
106
Canadian Natural Resources
CNQ
$93.8B
| $191M | 0.27% |
6,887,292
-19,320,694
| -74% | -$552M |
|
107
Petrobras Class A
PBR.A
$103B
| $189M | 0.27% |
20,392,485
-1,605,168
| -7% | -$17.2M |
|
108
Darden Restaurants
DRI
$24.4B
| $188M | 0.26% |
1,361,248
+299,154
| +28% | +$41.7M |
|
109
Qiagen
QGEN
$8.72B
| $185M | 0.26% |
3,489,599
+203,205
| +6% | +$10M |
|
110
Fidelity National Information Services
FIS
$22.1B
| $181M | 0.25% |
2,661,842
-158,981
| -6% | -$11.3M |
|
111
CrowdStrike
CRWD
$218B
| $175M | 0.25% |
6,662,400
+114,084
| +2% | +$3.9M |
|
112
Ally Financial
ALLY
$13.3B
| $173M | 0.24% |
7,062,564
+1,176,804
| +20% | +$31.3M |
|
113
Waste Management
WM
$91B
| $169M | 0.24% |
1,078,959
-196,984
| -15% | -$31.7M |
|
114
PNC Financial Services
PNC
$101B
| $169M | 0.24% |
1,070,084
-689,331
| -39% | -$108M |
|
115
Target
TGT
$68B
| $168M | 0.24% |
1,129,479
-724,834
| -39% | -$114M |
|
116
Tyson Foods
TSN
$20.4B
| $167M | 0.23% |
2,682,998
+202,959
| +8% | +$13.2M |
|
117
Sanofi
SNY
$104B
| $166M | 0.23% |
3,426,229
-573,617
| -14% | -$25.2M |
|
118
Tapestry
TPR
$32.8B
| $161M | 0.22% |
4,215,099
+544,424
| +15% | +$18.6M |
|
119
Chipotle Mexican Grill
CMG
$41.5B
| $158M | 0.22% |
5,701,300
+1,062,950
| +23% | +$31.8M |
|
120
Colgate-Palmolive
CL
$74.4B
| $158M | 0.22% |
1,999,895
-301,807
| -13% | -$22.6M |
|
121
Amdocs
DOX
$6.22B
| $157M | 0.22% |
1,722,404
+33,286
| +2% | +$2.83M |
|
122
Coca-Cola Europacific Partners
CCEP
$47.9B
| $156M | 0.22% |
2,818,483
-237,137
| -8% | -$11.9M |
|
123
Kimberly-Clark
KMB
$36.5B
| $153M | 0.21% |
1,123,526
+455,833
| +68% | +$57.9M |
|
124
Emerson Electric
EMR
$88.3B
| $152M | 0.21% |
1,587,271
-155,068
| -9% | -$13.9M |
|
125
Pinduoduo
PDD
$131B
| $150M | 0.21% |
1,841,473
-2,104,319
| -53% | -$146M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.